The Weekly Twitter Roundup

Posted by Dan Vorhaus on October 16, 2009

Each week there are a number of stories and developments that, for one reason or another, don’t find their way into a full-length posting on the Genomics Law Report. Here’s a recap of what I was Tweeting this week @genomicslawyer:

What ELSI is New? “Personalized Medicine in the Web 2.0 Era” http://bit.ly/PJZHh (from @Berci)
To Share or Not to Share: That is the Question http://bit.ly/1Ziz9j Should clinically relevant genetic research be returned to participants?
Detailed analysis of the Human Genetics Commission’s draft principles for DTC genetic testing: http://bit.ly/pab7b
What ELSI is New? @edyson on how we’ll handle the capability & responsibility of designing human life http://bit.ly/1lH3K3
RT @dgmacarthur @GenCounsNews: Myriad Genetics criticized for discouraging MD referrals to genetic counselors: http://bit.ly/1d7Lxj
RT @PHGFoundation Recommendation to exempt US gene patents from infringement http://bit.ly/3qwbrw
What ELSI is New? “We must revolutionize our communication of science to non-scientists” http://bit.ly/mPAsm from @girlscientist
“How will medicine and its regulation adapt to the information age?” From Andro Hsu of @23andMe http://bit.ly/14WIir
Re-identification and its Discontents: http://bit.ly/2OCRFk The limits of genomic privacy in research and commerce
From Bench to Market http://bit.ly/X1ZXd Series explores key issues scientist-entrepreneurs face in commercializing research; topics welcome
What ELSI is New? “The Risk of Communicating Risk” from @nanopore http://bit.ly/apatZ